Tomljenovic L, Shaw CA. Early career postdoctoral fellow in the Neural Dynamics Research Group at the University of British Columbia. Professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia and holds cross appointments with the Program in Experimental Medicine and the Graduate Program in Neuroscience. Abstract There are not many […]
GSK’s MenHibrix Approval: What is Wrong with this Picture?
[SaneVax: MenHibrix vaccine, manufactured by GlaxoSmithKline, was just approved for use in the U.S. based on data gathered from the inoculation of 7,521 infants and toddlers in five countries with ‘at least one dose.’ The problem is, this vaccine is given in a four dose regimen. How did the FDA determine that this vaccine was […]
SaneVax Writes Open Letter to Kathleen Sebelius, Secretary of Health: Rescind approval of Gardasil® due to lack of efficacy during post-licensure monitoring
By Norma Erickson, President. According to a recently published, industry-sponsored study conducted on 12,852 young women, HPV vaccination was found to reduce HPV-16 infections a mere 0.6% in vaccinated women versus unvaccinated women. At the same time, other high-risk (carcinogenic) HPV infections were diagnosed in vaccinated women 2.6% to 6.2% more frequently […]
FDA approves Roche HPV test to identify cervical cancer risk
Submitted by Mechele R. Dillard The U.S. Food and Drug Administration has approved a test identifying women at highest risk for cervical cancer. The U.S. Food and Drug Administration has approved the Roche cobas HPV(Human Papillomavirus) Test, which identifies women at highest risk for cervical cancer. It can potentially help doctors make earlier, more accurate […]
